SuicidalityMedicinal Chemistry & Drug DevelopmentLSD

Is LSD toxic?

This study (2018) re-examined five cases of fatality described by media as related to LSD toxicity, and found that none of those cases were actually attributable to physiological LSD toxicity.

Authors

  • David Nichols
  • Charles Grob

Published

Forensic Science International
meta Study

Abstract

LSD (lysergic acid diethylamide) was discovered almost 75 years ago, and has been the object of episodic controversy since then. While initially explored as an adjunctive psychiatric treatment, its recreational use by the general public has persisted and on occasion has been associated with adverse outcomes, particularly when the drug is taken under suboptimal conditions. LSD’s potential to cause psychological disturbance (bad trips) has been long understood, and has rarely been associated with accidental deaths and suicide. From a physiological perspective, however, LSD is known to be non-toxic and medically safe when taken at standard dosages (50-200 μg). The scientific literature, along with recent media reports, have unfortunately implicated “LSD toxicity” in five cases of sudden death. On close examination, however, two of these fatalities were associated with ingestion of massive overdoses, two were evidently in individuals with psychological agitation after taking standard doses of LSD who were then placed in maximal physical restraint positions (hogtied) by police, following which they suffered fatal cardiovascular collapse, and one case of extreme hyperthermia leading to death that was likely caused by a drug substituted for LSD with strong effects on central nervous system temperature regulation (e.g. 25i-NBOMe). Given the renewed interest in the therapeutic potential of LSD and other psychedelic drugs, it is important that an accurate understanding be established of the true causes of such fatalities that had been erroneously attributed to LSD toxicity, including massive overdoses, excessive physical restraints, and psychoactive drugs other than LSD.

Available with Blossom Pro

Research Summary of 'Is LSD toxic?'

Introduction

Nichols and colleagues situate LSD (lysergic acid diethylamide) as a semi-synthetic compound derived from ergot that was first synthesised in 1938 and discovered to be psychoactive in 1943. Early clinical work from the 1950s–1960s encompassed roughly 40,000 treated subjects and about 1,000 case reports, with comprehensive reviews from that era reporting low rates of adverse effects. The passage of the Controlled Substances Act in 1970 halted FDA‑approved LSD studies in the United States, although recent controlled studies have resumed in Europe. The paper addresses a persistent public and medico-legal question: is LSD physiologically toxic at standard recreational or investigational doses (commonly discussed in the paper as 50–200 units, noting extraction inconsistencies in unit reporting)? Nichols and colleagues aim to clarify reported fatalities allegedly due to LSD by reviewing case reports, pharmacokinetic data, and forensic findings, and to distinguish deaths plausibly caused by LSD itself from those resulting from massive overdoses, positional/physical restraint, or other psychoactive compounds substituted for LSD. The authors argue this clarification is important given renewed clinical interest in psychedelic therapies.

Expert Research Summaries

Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.

Study Details

References (18)

Papers cited by this study that are also in Blossom

Lysergic acid diethylamide: side effects and complications

Cohen, S. · Journal of Nervous and Mental Disease (1980)

Adverse Reactions to Psychedelic Drugs - A Review of the Literature

Strassman, R. J. · Journal of Nervous and Mental Disease (1984)

273 cited
The paradoxical psychological effects of lysergic acid diethylamide (LSD)

Carhart-Harris, R. L., Kaelen, M., Bolstridge, M. et al. · Psychological Medicine (2016)

253 cited
LSD enhances suggestibility in healthy volunteers

Carhart-Harris, R. L., Kaelen, M., Whalley, M. G. et al. · Psychopharmacology (2014)

257 cited
Neural correlates of the LSD experience revealed by multimodal neuroimaging

Carhart-Harris, R. L., Muthukumaraswamy, S., Roseman, L. et al. · PNAS (2016)

Acute effects of lysergic acid diethylamide in healthy subjects

Schmid, Y., Enzler, F., Gasser, P. et al. · Biological Psychiatry (2015)

Acute effects of lysergic acid diethylamide on circulating steroid levels in healthy subjects

Strajhar, P., Schmid, Y., Liakoni, E. et al. · Journal of Neuroendocrinology (2016)

Modern clinical research on LSD

Liechti, M. E. · Neuropsychopharmacology (2017)

The fabric of meaning and subjective effects in LSD-induced states depend on serotonin 2A receptor activation

Preller, K. H., Herdener, M., Pokorny, T. et al. · Current Biology (2017)

Show all 18 references
Psychedelics and mental health: a population study

Krebs, T. S., Johansen, P. ˚. Ø. · PLOS ONE (2013)

LSD acutely impairs fear recognition and enhances emotional empathy and sociality

Dolder, P. C., Schmid, Y., Müller, F. et al. · Neuropsychopharmacology (2016)

Pharmacokinetics and pharmacodynamics of lysergic acid diethylamide in healthy subjects

Dolder, P. C., Schmid, Y., Steuer, A. E. et al. · Clinical Pharmacokinetics (2017)

Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population

Hendricks, P. S., Thorne, C. B., Clark, B. et al. · Journal of Psychopharmacology (2015)

345 cited
Pharmacokinetics and concentration-effect relationship of oral LSD in humans

Dolder, P. C., Schmid, Y., Haschke, M. et al. · International Journal of Neuropsychopharmacology (2015)

97 cited
Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens

Rickli, A., Moning, O. D., Hoener, M. C. et al. · European Neuropsychopharmacology (2016)

Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases

Gasser, P., Holstein, D., Michel, Y. et al. · Journal of Nervous and Mental Disease (2014)

594 cited

Cited By (4)

Papers in Blossom that reference this study

LSD microdosing in major depressive disorder: results from an open-label trial

Daldegan-Bueno, D., Donegan, C. J., Sumner, R. L. et al. · Neuropharmacology (2026)

Association between Lifetime Classic Psychedelic Use and Sick Leave in a Population-Based Sample

Mellner, C., Dahlen, M., Simonsson, O. · International Journal of Environmental Research and Public Health (2022)

Association Between Lifetime Classic Psychedelic Use and Hypertension in the Past Year

Simonsson, O., Hendricks, P. S., Carhart-Harris, R. et al. · Hypertension (2021)

28 cited

Your Personal Research Library

Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.